BlackRock, Inc. filed an amended beneficial ownership statement with the SEC on October 27, 2026, disclosing its holdings in STAAR Surgical Co common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: BlackRock reported holding 4,611,827 shares of STAAR Surgical Co common stock, representing 9.2% of the class.
  • Sole voting power: BlackRock disclosed sole voting power over 4,534,467 shares.
  • Sole dispositive power: BlackRock disclosed sole dispositive power over 4,611,827 shares.
  • Shared voting and dispositive power: Both figures are reported as 0 shares.
  • Amendment number: This filing is Amendment No. 20 to the original statement.
  • Reporting person type: BlackRock is classified as a holding company (HC) incorporated in Delaware.

BlackRock's Reported Position in STAAR Surgical as of September 2026

According to the filing, BlackRock, Inc., headquartered at 50 Hudson Yards, New York, NY 10001, reported an aggregate beneficial ownership of 4,611,827 shares of STAAR Surgical Co common stock (CUSIP 852312305) as of September 30, 2026. This represents 9.2% of the outstanding class, as stated in the filing. The event date triggering this amended disclosure was September 30, 2026, and the statement was signed by Spencer Fleming, Managing Director, on October 27, 2026.

STAAR Surgical Co, whose principal executive offices are located at 25510 Commercentre Drive, Lake Forest, CA 92630, is an ophthalmic device company. The filing notes that the reported ownership reflects securities beneficially owned or deemed beneficially owned by certain business units of BlackRock and its subsidiaries and affiliates, described collectively as the "Reporting Business Units," consistent with SEC Release No. 34-39538 dated January 12, 1998. Securities held by other BlackRock business units whose beneficial ownership is disaggregated from those units are not included in the reported totals, according to the filing.

The filing further states that various persons have the right to receive or direct the receipt of dividends from, or proceeds from the sale of, STAAR Surgical common stock, but that "no one person's interest in the common stock of STAAR SURGICAL CO is more than five percent of the total outstanding common shares." BlackRock certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of STAAR Surgical Co.

What Was Disclosed

BlackRock, Inc. filed Amendment No. 20 to its Schedule 13G disclosing beneficial ownership of 4,611,827 shares, or 9.2%, of STAAR Surgical Co common stock as of September 30, 2026, with sole voting power over 4,534,467 shares and no shared voting or dispositive power.